| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
118,610,000 |
| Market
Cap: |
23.41(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1974 - $0.2732 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oncocyte is a molecular diagnostics company focused on developing and commercializing proprietary laboratory-developed tests to serve unmet medical needs across the cancer care continuum. Co.'s DetermaRx™ is a predictive molecular test for early-stage adenocarcinoma of the lung. This test provides information that a physician can use to help identify early-stage, surgically resected patients with Stage I and IIA non-squamous non-small cell lung cancer who are at high-risk of recurrence and may benefit from chemotherapy. Co.'s portfolio includes a gene expression-based test called DetermaIO™, which is being developed to identify patients most likely to respond to immunotherapy drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,457,288 |
2,457,288 |
2,487,288 |
30,608,426 |
| Total Buy Value |
$7,167,688 |
$7,167,688 |
$7,174,135 |
$15,854,134 |
| Total People Bought |
3 |
3 |
4 |
10 |
| Total Buy Transactions |
4 |
4 |
5 |
20 |
| Total Shares Sold |
0 |
0 |
0 |
107,514 |
| Total Sell Value |
$0 |
$0 |
$0 |
$111,901 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bradsher Neal C |
10% Owner |
– – • |
2021-01-20 |
4 |
B |
$3.42 |
$4,999,999 |
D/D |
1,460,280 |
16,176,484 |
2.45 |
12% |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-28 |
4 |
OE |
$1.34 |
$87,463 |
D/D |
65,271 |
384,111 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-23 |
4 |
S |
$2.55 |
$2,295 |
D/D |
(900) |
318,840 |
|
-70% |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-23 |
4 |
OE |
$1.34 |
$1,658 |
D/D |
1,237 |
319,740 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-22 |
4 |
S |
$0.00 |
$0 |
D/D |
(7,652) |
318,503 |
|
-75% |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-22 |
4 |
OE |
$1.34 |
$14,091 |
D/D |
10,516 |
326,155 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-21 |
4 |
S |
$0.00 |
$13,076 |
D/D |
(35,148) |
315,639 |
|
-87% |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-21 |
4 |
OE |
$1.34 |
$64,288 |
D/D |
47,976 |
350,787 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,909 |
302,811 |
|
- |
|
| Levine Mitchell S |
CFO |
• – – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,121 |
46,700 |
|
- |
|
| Parker Albert P |
COO |
• – – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,586 |
10,586 |
|
- |
|
| Sundar Padma |
SVP, Marketing & Market Access |
• – – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,177 |
4,177 |
|
- |
|
| Ross Douglas T. |
CMO |
• – – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,317 |
5,317 |
|
- |
|
| Redmond Cavan M. |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,416 |
70,863 |
|
- |
|
| Arno Andrew |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,602 |
112,049 |
|
- |
|
| Hesterberg Lyndal K. |
CSO |
• – – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,603 |
7,477 |
|
- |
|
| Last Andrew J. |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
16,184 |
23,177 |
|
- |
|
| Levine Mitchell S |
CFO |
• – – |
2020-09-12 |
4/A |
B |
$2.01 |
$20,060 |
D/D |
10,000 |
13,495 |
2.74 |
- |
|
| Parker Albert P |
Chief Operating Officer |
• – – |
2020-08-03 |
4 |
B |
$1.33 |
$6,648 |
D/D |
5,000 |
5,000 |
2.74 |
33% |
|
| Kalajian Tony T |
Sr.VP/Chief Accounting Officer |
• – – |
2020-08-03 |
4 |
B |
$1.31 |
$6,533 |
D/D |
5,000 |
15,000 |
2.74 |
33% |
|
| Levine Mitchell S |
Chief Financial Officer |
• – – |
2020-08-03 |
4 |
B |
$1.32 |
$13,200 |
D/D |
10,000 |
36,579 |
2.74 |
33% |
|
| Andrews Ronald Asbury |
Chief Executive Officer |
• • – |
2020-08-03 |
4 |
B |
$1.35 |
$53,880 |
D/D |
40,000 |
102,698 |
2.81 |
33% |
|
| Bradsher Neal C |
10% Owner |
– – • |
2020-04-24 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
14,716,204 |
1.42 |
-46% |
|
| Bradsher Neal C |
10% Owner |
– – • |
2020-04-24 |
4 |
B |
$2.27 |
$2,383,500 |
D/D |
1,050,000 |
14,716,204 |
2.45 |
-46% |
|
| Andrews Ronald Asbury |
CEO and President |
• • – |
2020-03-31 |
4 |
B |
$2,372.00 |
$42,696,000 |
D/D |
18,000 |
62,698 |
2.81 |
-15% |
|
142 Records found
|
|
Page 4 of 6 |
|
|
